Intellectual Property India Publishes Patent Application for '4-(3,8-Diazabicyclo[3.2.1]Octan-3-Yl)-7-Naphthalene-Pyrido[4,3-D]Pyrimidine Derivatives As Inhibitors Of The Kras(G12d) Mutant Oncoproteine For The Treatment Of Cancer' Filed by Ranok Therapeutics (HANGZHOU) Co. Ltd.

MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517026998 A) filed by Ranok Therapeutics (HANGZHOU) Co. Ltd., Zhejiang, China, on March 24, for '4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-naphthalene-pyrido[4,3-d]pyrimidine derivatives as inhibitors of the kras(g12d) mutant oncoproteine for the treatment of cancer.'

Inventor(s) include Ying, Weiwen; Ying, Chenghao; Foley, Kevin, P.; Wang, Zhiyong; Yin, Wei; Ma, Liang; Wang, Guoqiang; Li, Jinhua; Wang, Yaya; Dai, Yan; and Prince, Thomas.

The application for the patent was published on May 16, under issue no. 20/2025.

According to the abstract released by the Intellectual Property India: "Provided are small molecule inhibitors of the KRAS(G12D) muta...